Back to Search
Start Over
A Pilot Study of the Association of Amino-Terminal Pro-B-Type Natriuretic Peptide and Severity of Illness in Pediatric Septic Shock
- Source :
- Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 20(2)
- Publication Year :
- 2018
-
Abstract
- Objectives: Biomarkers that can measure illness severity and predict the risk of delayed recovery may be useful in guiding pediatric septic shock. Amino-terminal pro-B-type natriuretic peptide has not been assessed in pediatric septic patients at the time of presentation to the emergency department prior to any interventions. The primary aim was to assess if emergency department amino-terminal pro-B-type natriuretic peptide is associated with worse outcomes and severity of illness. Design: Prospective observational pilot study. Settings: Tertiary free-standing children’s hospital. Patients: Children 0–17 years old with a diagnosis of septic shock were enrolled. Patients with preexisting cardiac and renal dysfunction were excluded. Interventions: None. Measurements and Main Results: Amino-terminal pro-B-type natriuretic peptide analysis was performed on samples obtained in the emergency department prior to any intervention. The association between biomarkers and clinical outcomes and illness severity using Pediatric RISk of Mortality 3 were assessed. Eighty-two patients with septic shock underwent analysis. The median (interquartile range) amino-terminal pro-B-type natriuretic peptide levels was 394 pg/mL (102–1,392 pg/mL). Each decile change increase in amino-terminal pro-B-type natriuretic peptide was associated with a change in ICU length of stay by 8.7%, (95% CI, 2.4–15.5), hospital length of stay by 5.7% (95% CI, 0.4–11.2), organ dysfunction by 5.1% (95% CI, 1.8–8.5), a higher inotropic score at 12, 24, and 36 hours, and longer time requiring vasoactive agents. There was a significant correlation between baseline amino-terminal pro-B-type natriuretic peptide and the Pediatric RISk of Mortality 3 score (Spearman rho = 0.247; p = 0.029). Conclusions: This pilot study shows an association between emergency department amino-terminal pro-B-type natriuretic peptide on presentation and worse septic shock outcomes and amino-terminal pro-B-type natriuretic peptide levels correlates with an ICU severity score.
- Subjects :
- Male
medicine.medical_specialty
medicine.drug_class
Pilot Projects
Critical Care and Intensive Care Medicine
Intensive Care Units, Pediatric
Severity of Illness Index
Tertiary Care Centers
Interquartile range
Internal medicine
Severity of illness
Natriuretic Peptide, Brain
Risk of mortality
medicine
Natriuretic peptide
Humans
Vasoconstrictor Agents
Prospective Studies
business.industry
Septic shock
Organ dysfunction
Emergency department
Length of Stay
medicine.disease
Hospitals, Pediatric
Prognosis
Shock, Septic
Peptide Fragments
Shock (circulatory)
Pediatrics, Perinatology and Child Health
Female
medicine.symptom
business
Emergency Service, Hospital
Biomarkers
Subjects
Details
- ISSN :
- 15297535
- Volume :
- 20
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
- Accession number :
- edsair.doi.dedup.....406c817d8c475409fb334084319c4c87